Cite
The efficacy of somatostatin analogues in the treatment of diabetic retinopathy and thyroid eye disease.
MLA
Krassas, Gerasimos E., et al. “The Efficacy of Somatostatin Analogues in the Treatment of Diabetic Retinopathy and Thyroid Eye Disease.” Clinical Ophthalmology (Auckland, N.Z.), vol. 1, no. 3, Sept. 2007, pp. 209–15. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=19668474&authtype=sso&custid=ns315887.
APA
Krassas, G. E., Tzotzas, T., Papazisis, K., Pazaitou-Panayiotou, K., & Boboridis, K. (2007). The efficacy of somatostatin analogues in the treatment of diabetic retinopathy and thyroid eye disease. Clinical Ophthalmology (Auckland, N.Z.), 1(3), 209–215.
Chicago
Krassas, Gerasimos E, Themistoklis Tzotzas, Konstantinos Papazisis, Kaliopi Pazaitou-Panayiotou, and Kostas Boboridis. 2007. “The Efficacy of Somatostatin Analogues in the Treatment of Diabetic Retinopathy and Thyroid Eye Disease.” Clinical Ophthalmology (Auckland, N.Z.) 1 (3): 209–15. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=19668474&authtype=sso&custid=ns315887.